Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
Jorge Sierra(Universitat Autònoma de Barcelona), JUAN F MARTINEZ ORTEGA(Hospital Materno-Infantil), Errol Véla(Université de Montpellier), Evarist Feliú(Universitat Autònoma de Barcelona), Carlos Besses(Hospital Del Mar), Javier Bueno(University of Pittsburgh), Enric Carreras(Josep Carreras Leukaemia Research Institute), P Vivancos, Isabel Badell(Hospital de Sant Pau), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Emili Montserrat(Universitat de Barcelona), Antònia Domingo‐Salvany, Josep‐María Ribera(Universitat Autònoma de Barcelona), C Rozmán(Universitat de Barcelona), R. Guardia, J. Maciá, M Rovira, Andreu Llorente, J Petit, A Grañena, J Cubells, Antoni Juliá, Salut Brunet(Institut Català d'Oncologia)
Cited by 40
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k